Women’s Health Initiative

Women’s health is shaped by more than clinical innovation alone. Coverage, affordability, fragmented care, underrepresentation in research, and uneven access can determine whether a solution reaches the people it was designed to serve.

With an understanding of these challenges, the Women’s Health Initiative at Avalere Health helps organizations:

• Generate evidence that demonstrates clinical, economic, and societal value
• Navigate evolving policy, coverage, coding, and reimbursement pathways
• Understand the priorities of patients, providers, payers, and policymakers
• Identify access barriers and opportunities across diverse populations
• Translate insight into practical market and commercialization strategies

At Avalere Health, we believe in EVERY PATIENT POSSIBLE – and we cannot reach every patient if 50% of the population is left behind.

The Women’s Health Initiative sits within Avalere Health Advisory, which helps organizations navigate  interconnected challenges. We bring together scientific and market evidence, policy and reimbursement expertise, patient and stakeholder perspectives, and commercial strategy to help advance solutions, from unmet need to meaningful real-world impact.

 

Meet our women’s health experts

Dr. Laura Housman, SVP and Evidence & Strategy Practice Director; Chief Public Health Officer: Laura works at the intersection of evidence, commercialization, market access, and public health, helping organizations translate healthcare innovation into improved outcomes and measurable value.

Monica Pham, Managing Director, Policy: Monica partners with clients to shape federal and state strategic policy, by translating coverage, reimbursement, patient affordability, market access considerations and SDOH into commercial decision points, shaping the path from innovation to patient access in therapeutic areas such as neurology, maternal health, autoimmune, and rare disease.

Agata Pelka, Principal, Policy: Agata helps clients translate complex federal and state policy developments—including coverage, benefit design, affordability, and patient-access considerations—into practical business strategies.

Naila Wahid, Principal, Evidence & Strategy: Naila advises clients on commercial and policy issues related to quality measures and performance. She applies her project management experience and background in policy, hospital administration, and patient protections to provide evidence-based solutions.

Ayesha Azam, Senior Director, Client Partnerships: Ayesha advises life sciences clients on policy, commercialization, and patient access strategies in response to a complex, evolving healthcare landscape. Her research focuses on gender and racial disparities in quality of care, including differences in treatment patterns, access, and outcomes across patient populations.

Christina Gramling, Director, Client Partnerships: Christina advises life sciences organizations on how the evolving healthcare landscape may impact their business priorities across policy, health equity, health economics outcomes research, and market access functions

Jasmine Nicole Namata, Senior Manager, Client Partnerships: Jasmine Nicole advises life science organizations, health plans, and patient and trade associations on how the evolving healthcare landscape may impact their policy, access, and evidentiary business strategies.